Myelination in the absence of galactolipids and proteolipid proteins

Molecular and Cellular Neurosciences

Volumn 14, Issue 1, 1999, Pages 41-51

  Coetzee, Timothy ^a   Suzuki, Kinuko ^a   Nave, Klaus Armin ^c   Popko, Brian ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYLCERAMIDE; PROTEOLIPID PROTEIN; SULFATIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATAXIA; BRAIN DEGENERATION; CEREBELLUM DEGENERATION; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MOUSE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; ULTRASTRUCTURE;

EID: 0032781971     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.1999.0768     Document Type: Article

References (30)

1. Barbour S., Edidin M., Felding-Habermann B., Taylor-Norton J., Radin N. S., Fenderson B. A. Glycolipid depletion using a ceramide analogue (PDMP) alters growth, adhesion, and membrane lipid organization in human A431 cells. J. Cell. Physiol. 150:1992;610-619.
2. Bosio A., Binczek E., Stoffel W. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc. Natl. Acad. Sci. USA. 93:1996;13280-13285.
3. Bosio A., Binczek E., Haupt F. W., Stoffel W. Composition and biophysical properties of myelin lipid define the neurological defects in galactocerebroside- and sulfatide-deficient mice. J. Neurochem. 70:1998;308-315.
4. Cestaro B., Cervato G., Marchesini S., Viani P., Pistolesi E., Oliva C. Electron spin resonance studies on the dynamics of phosphatidylcholine-sulfatide model membranes. Chem. Phys. Lipids. 33:1983;251-262.
5. Coetzee T., Fujita F., Dupree J., Shi R., Blight A., Suzuki K., Suzuki K., Popko B. Myelination in the absence of galactocerebroside and sulfatide: Normal structure with abnormal function and regional instability. Cell. 86:1996;209-219.
6. Coetzee T., Dupree J. L., Popko B. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice. J. Neurosci. Res. 54:1998;613-622.
7. Dickinson P. J., Fanarraga M. L., Griffiths I. R., Barrie J. A., Kyriakides E., Montague P. Oligodendrocyte progenitors in the embryonic spinal cord express DM-20. Neuropathol. Appl. Neurobiol. 22:1996;188-198.
8. Dupree J. L., Coetzee T., Blight A., Suzuki K., Popko B. Myelin galactolipids are essential for proper node of Ranvier formation in the CNS. J. Neurosci. 18:1998a;1642-1649.
9. Dupree J. L., Coetzee T., Popko B. Myelin abnormalities in mice deficient in galactocerebroside and sulfatide. J. Neurocytol. 27:1998b;649-659.
10. Dupree J. L., Suzuki K., Popko B. Galactolipids in the formation and function of the myelin sheath. Microsc. Res. Tech. 41:1998c;431-440.
11. Griffiths I., Klugmann M., Anderson T., Thomson C., Vouyiouklis D., Nave K-A. Current concepts of PLP and its role in the nervous system. Microsc. Res. Tech. 41:1998a;344-358.
12. Griffiths I., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M. H., Scheider A., Zimmerman F., McCulloch M., Nadon N., Nave K-A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science. 280:1998b;1610-1613.
13. Ikenaka K., Kagawa T., Mikoshiba K. Selective expression of DM-20, an alternatively spliced myelin proteolipid protein gene product, in developing nervous system and in nonglial cells. J. Neurochem. 58:1992;2248-2253.
14. Kirschner D., Ganser A. L., Caspar D. L. D. Diffraction studies of molecular organization and membrane interactions in myelin. Morell P. Myelin. 1984;51-95 Plenum, New York.
15. Klugmann M., Schwab M., Pühlhofer, Schneider A., Zimmerman F., Griffiths I. R., Nave K-A. Assembly of CNS myelin in the absence of proteolipid protein. Neuron. 18:1997;59-70.
16. 3 sulfate by electrospray ionization mass spectrometry. J. Biol. Chem. 271:1996;3496-3499.
17. Lees M., Brostoff S. L. Proteins of myelin. Morell P. Myelin. 1984;197-224 Plenum, New York.
18. Martini R., Mohajeri M. H., Kasper S., Giese K. P., Schachner M. Mice doubly deficient in the genes for P0 and myelin basic protein shown that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J. Neurosci. 15:1995;4488-4495.
19. Milner R. J., Lai C., Nave K-A., Lenoir D., Ogata J., Sutcliffe J. G. Nucleotide sequences for two mRNAs for rat brain myelin proteolipid protein. Cell. 42:1985;931-939.
20. Morell P., Quarles R. H., Norton W. T. Myelin formation, structure, and biochemistry. Siegel B. W., Agranoff R. W., Albers P., Molinoff B. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. 1994;147-195 Raven Press, New York.
21. Nave K-A., Lai C., Bloom F. E., Milner R. J. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of the central nervous system myelin. Proc. Natl. Acad. Sci. USA. 84:1987;5665-5669.
22. Popot J., Pham Dihn D., Dautigny A. Major myelin proteolipid: The 4-alpha-helix topology. J. Membr. Biol. 120:1991;233-246.
23. Raff M. C., Mirsky R., Fields K. L., Lisak R. P., Dorfman S. H., Silberberg D. H., Gregson N. A., Leibowitz S., Kennedy M. D. Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature. 274:1978;813-816.
24. Readhead C., Popko B., Takahashi N., Shine H., Saavedra R., Sidman R., Hood L. Expression of myelin basic protein in transgenic shiverer mice: Correction of the dysmyelinating phenotype. Cell. 48:1987;702-712.
25. Reynolds R., Wilkin G. P. Development of macroglial cells in the rat cerebellum II. An in situ immunohistochemical study of oligodendroglial lineage from precursor to mature myelinating cell. Development. 102:1988;409-425.
26. Roach A., Boylan K., Horvath S., Prusiner S., Hood L. Chromosomal mapping of mouse myelin basic protein gene and structure and transcription of the partially deleted gene in shiverer mutant mice. Cell. 42:1985;149-155.
27. Rosenbluth J., Stoffel W., Schiff R. Myelin structure in proteolipid protein (PLP)-null mouse spinal cord. J. Comp. Neurol. 371:1996;336-344.
28. Stewart R., Boggs J. M. A carbohydrate-carbohydrate interaction between galactosylceramide-containing liposomes and cerebroside sulfate-containing liposomes: Dependence on the glycolipid ceramide composition. Biochemistry. 32:1993;10666-10674.
29. Timsit S., Martinez S., Allinquant B., Peyron F., Puelles L., Zalc B. Oligodendrocytes originate in a restricted zone of the embryonic ventral neural tube defined by DM20 mRNA expression. J. Neurosci. 15:1995;1012-1024.
30. Weimbs T., Stoffel W. Proteolipid protein (PLP) of CNS myelin: Positions of free, disulfide bonded, and fatty-acid thioesterase-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry. 31:1992;12289-12296.